Alexion Pharmaceuticals, Inc.

Impax Asset Management Group plc ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/5/2021

Shares

230,870

Value ($000)

42,413

Weight

0.2%

2019 Q4 - 2021 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/5/2021	42,413	0.2%	230,870	6/30/2021
2021 Q1	5/14/2021	118,146	0.6%	772,649	3/31/2021
2020 Q4	2/16/2021	104,918	0.7%	671,520	12/31/2020
2020 Q3	11/12/2020	74,527	0.7%	651,290	9/30/2020
2020 Q2	8/14/2020	54,036	0.6%	481,431	6/30/2020
2020 Q1	5/15/2020	35,507	0.5%	395,440	3/31/2020
2019 Q4	2/13/2020	13,099	0.1%	121,122	12/31/2019